ikarovec
www.ikarovec.comThe company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
Read more
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
Read more
Country
City (Headquarters)
Norwich
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Director
Email ****** @****.comPhone (***) ****-****
Technologies
(7)
Reach decision makers at ikarovec
Free credits every month!
ikarovec FAQ
Norwich, United Kingdom
Biotechnology Research
